Treatment**

Concentration
(ppm)

Fungi tested

Fusarium oxysporum

Fusarium solani

Rhizoctonia solani

Sclerotium rolfesii

 

A

100

18.9  e

22.2  c

26.7  c

28.9  c

200

25.6  c

29.9  c

41.1  d

43.3  d

400

46.7  d

45.6  d

51.1  bc

52.2  bc

600

61.1  b

63.3  b

66.7  b

68.9  b

800

100  a

100  a

100  a

100  a

 

B

100

21.1  c

24.4  c

27.8  c

31.1  cd

200

26.7  c

38.9  cd

35.6  cd

42.2  d

400

53.3  bc

55.6  bc

56.7  bc

64.4  b

600

63.3  b

100  a

100  a

68.9  b

800

100  a

100  a

100  a

100  a

 

C

100

10.0  e

12.2  e

11.1  e

8.9  e

200

15.5  e

17.8  e

16.7  e

18.9  e

400

24.4  c

22.2  c

23.3  c

25.6  c

600

41.1  d

43.3  d

46.7  d

54.4  bc

800

100  a

61.1  b

100  a

100  a

 

D

100

13.3  e

14.4  e

26.7  c

15.6  e

200

31.1  cd

21.1  c

44.4  d

25.6  c

400

47.8  d

30.0  cd

47.8  d

46.7  d

600

100  a

51.1  bc

100  a

57.8  bc

800

100  a

100  a

100  a

100  a

 

A+B+C+D

100

46.7  d

73.8  b

40.0  d

60.0  b

200

100  a

100  a

100  a

100  a

400

100  a

100  a

100  a

100  a

600

100  a

100  a

100  a

100  a

800

100  a

100  a

100  a

100  a

Mean values within columns followed by the same letter are not significantly different at P<0.05 (n = 4).
* The fungal growth reduction in different treatments was calculated as percentage relatively to its growth in control treatment
**Where: A= Miconazole B= Chlorohexidine diglucanate C = Chlorocresol D= Hexamidine di-isothianate
Table 1: Reduction in fungal growth in response to different concentrations of some pharmaceutical compounds in vitro conditions.